等待開盤 09-20 09:30:00 美东时间
-0.170
-1.43%
Artiva Biotherapeutics press release (NASDAQ:ARTV): Q2 GAAP EPS of -$22.00. As of June 30, 2024, Artiva had cash, cash equivalents, and short-term investments of $46.6 million. In addition, Artiva com...
08-30 04:25
Artiva Biotherapeutics (NASDAQ:ARTV) reported quarterly losses of $(22.00) per share. This is a 56.14 percent decrease over losses of $(14.09) per share from the same period last year.
08-30 04:14
LIMASSOL, Kypr, 23. srpna 2024 /PRNewswire/ -- RoboMarkets s hrdostí oznamuje ...
08-23 21:26
Gil Blum, an analyst from Needham, has initiated a new Buy rating on Artiva Bio...
08-13 18:58
The U.S. IPO pipeline marches on its steady growth path, with Lineage (LINE) expected to raise upwards of $3.6 billion, which would repay the REIT's outstanding borrowings. Not only this, OneStream So...
07-22 22:29
Artiva Biotherapeutics (ARTV) climbed ~25% from its initial public offering price as the cell therapy developer made its public trading debut on Friday. Following an IPO priced at $12.00 apiece, ARTV ...
07-20 01:16
Artiva Biotherapeutics宣布了IPO条款,该公司以每股12美元的价格发行了1390万股股票,筹资1.67亿美元。
07-19 21:00
The shares are expected to begin trading on the Nasdaq Global Market on July 19, 2024, under the symbol "ARTV." The offering is expected to close on July 22, 2024, subject to the satisfaction of customary
07-19 14:27
Artiva Biotherapeutics, Inc (NASDAQ:ARTV) IPO will take place July, 19 on the N...
07-18 23:00